HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic

Varma, Niraj; Marrouche, Nassir F.; Aguinaga, Luis; Albert, Christine M.; Arbelo, Elena; Choi, Jong Il; Chung, Mina K.; Conte, Giulio; Dagher, Lilas; Epstein, Laurence M.; Ghanbari, Hamid; Han, Janet K.; Heidbüchel, Hein; Huang, He; Lakkireddy, Dhanunjaya; Ngarmukos, Tachapong; Russo, Andrea M.; Saad, Eduardo; Morales, Luis C. Sàenz; Sandau, Kristin E.; Sridhar, Arun Raghav Mahankali; Stecker, Eric C.; Varosy, Paul D.

doi:10.1016/j.hrthm.2020.06.010

Cited by 46 publications

(62 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…If drugs that have QT-prolonging effects are deemed necessary to be administered in an inpatient setting, a baseline 12-lead ECG should be acquired. Telemetry monitoring is reasonable when patients have multiple cardiovascular risk factors, and/or there is a risk for clinical decompensation [ 38 ]. The incidence of arrhythmias has also been associated with disease severity.…”

Section: Discussionmentioning

confidence: 99%

Arrhythmia in COVID-19

Babapoor-Farrokhran

Rasekhi

Gill

et al. 2020

SN Compr. Clin. Med.

103

102

View full text Add to dashboard Cite

The current outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) also known as coronavirus disease 2019 (COVID-19) has quickly progressed to a global pandemic. There are well-documented cardiac complications of COVID-19 in patients with and without prior cardiovascular disease. The cardiac complications include myocarditis, heart failure, and acute coronary syndrome resulting from coronary artery thrombosis or SARS-CoV-2-related plaque ruptures. There is growing evidence showing that arrhythmias are also one of the major complications. Myocardial inflammation caused by viral infection leads to electrophysiological and structural remodeling as a possible mechanism for arrhythmia. This could also be the mechanism through which SARS-CoV-2 leads to different arrhythmias. In this review article, we discuss arrhythmia manifestations in COVID-19.

show abstract

Section: Discussionmentioning

confidence: 99%

Arrhythmia in COVID-19

Babapoor-Farrokhran

Rasekhi

Gill

et al. 2020

SN Compr. Clin. Med.

103

102

View full text Add to dashboard Cite

show abstract

“…The assessment of quality of care delivered through RM [29], with appropriate involvement of the patients and the caregivers [30], will become of primary importance for outcome improvement. Anyway, as stressed in official documents of the major international associations in the field of arrhythmia management, the crisis precipitated by the pandemic has surely catalysed the adoption of RM across many specialties and heart rhythm professionals are in the front line for full adoption of this technological and clinical advancement even beyond the emergency of COVID-19 pandemic, making RM as the true standard of care in this field [31].…”

Section: Discussionmentioning

confidence: 99%

Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing)

Boriani

Palmisano²,

Guerra

et al. 2020

Intern Emerg Med

View full text Add to dashboard Cite

COVID-19 outbreak had a major impact on the organization of care in Italy, and a survey to evaluate provision of for arrhythmia during COVID-19 outbreak (March-April 2020) was launched. A total of 104 physicians from 84 Italian arrhythmia centres took part in the survey. The vast majority of participating centres (95.2%) reported a significant reduction in the number of elective pacemaker implantations during the outbreak period compared to the corresponding two months of year 2019 (50.0% of centres reported a reduction of > 50%). Similarly, 92.9% of participating centres reported a significant reduction in the number of implantable cardioverter-defibrillator (ICD) implantations for primary prevention, and 72.6% a significant reduction of ICD implantations for secondary prevention (> 50% in 65.5 and 44.0% of the centres, respectively). The majority of participating centres (77.4%) reported a significant reduction in the number of elective ablations (> 50% in 65.5% of the centres). Also the interventional procedures performed in an emergency setting, as well as acute management of atrial fibrillation had a marked reduction, thus leading to the conclusion that the impact of COVID-19 was disrupting the entire organization of health care, with a massive impact on the activities and procedures related to arrhythmia management in Italy.

show abstract

“…Important lessons have been and continue to be learnt during this on-going pandemic of COVID-19. Apparently, the need for contactless monitoring and telemetry for inpatients, especially those admitted to the ICU, as well as for outpatients needing continued management, has ushered in a new era in implementing digital health monitoring tools [92] . The use of smart watches, smartphones, and even smart beds (with elimination of cables and skin electrodes) for in-hospital telemetry, and even wireless monitoring after discharge, is a novel approach [93] .…”

Section: Digital Medicinementioning

confidence: 99%

COVID-19 infection and cardiac arrhythmias

Manolis¹,

Manolis

et al. 2020

Trends in Cardiovascular Medicine

112

View full text Add to dashboard Cite

Highlights Serious cardiac arrhythmias may be the consequence of direct effects of COVID-19 infection, but also the outcome of the deleterious effects of systemic illness and the adverse proarrhythmic reactions to drugs employed in the treatment of this pandemic Drug combinations, especially of QT-prolonging agents, can lead to higher arrhythmogenicity, compared with single drug therapies Furthermore, critically ill COVID-19 patients often have comorbidities that can trigger life-threatening ventricular arrhythmias, while acute myocardial injury increases the prevalence of arrhythmias ECG and QTc monitoring and taking appropriate measures are of critical importance to prevent, detect and manage cardiac arrhythmias in COVID-19 patients Contactless monitoring and telemetry for inpatients, especially those admitted to the ICU, as well as for outpatients needing continued management, has recently been facilitated by implementing digital health monitoring tools

show abstract

HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic

Cited by 46 publications

References 52 publications

Arrhythmia in COVID-19

Arrhythmia in COVID-19

Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing)

COVID-19 infection and cardiac arrhythmias

Contact Info

Product

Resources

About